NEFECON(R) Included in National Reimbursement Drug List (NRDL)

Posted by | Nov 29, 2024 | |

HONG KONG, Nov 29, 2024 – (ACN Newswire) – On November 28, the National Healthcare Security Administration (NHSA) and the Ministry of Human Resources and Social Security announced the “National Reimbursement Drug List (2024)” (NRDL), which will officially take effect on January 1, 2025. NEFECON(R), the first etiological treatment for IgA nephropathy developed by Everest

Read More